GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaron Beijing Co Ltd (SZSE:300759) » Definitions » Pre-Tax Income

Pharmaron Beijing Co (SZSE:300759) Pre-Tax Income : ¥1,680 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Pharmaron Beijing Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Pharmaron Beijing Co's pretax income for the three months ended in Mar. 2024 was ¥269 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,680 Mil. Pharmaron Beijing Co's pretax margin was 10.06%.

During the past 10 years, Pharmaron Beijing Co's highest Pretax Margin was 25.70%. The lowest was 3.66%. And the median was 14.72%.


Pharmaron Beijing Co Pre-Tax Income Historical Data

The historical data trend for Pharmaron Beijing Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaron Beijing Co Pre-Tax Income Chart

Pharmaron Beijing Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 632.55 1,319.37 1,911.00 1,666.39 1,837.89

Pharmaron Beijing Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 426.60 481.92 412.42 516.94 268.62

Competitive Comparison of Pharmaron Beijing Co's Pre-Tax Income

For the Biotechnology subindustry, Pharmaron Beijing Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmaron Beijing Co's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmaron Beijing Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Pharmaron Beijing Co's Pre-Tax Income falls into.



Pharmaron Beijing Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Pharmaron Beijing Co's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=1833.329+0+-182.192+33.543+153.207
=1,838

Pharmaron Beijing Co's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=312.876+0+-70.568+-24.328+50.639
=269

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,680 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmaron Beijing Co  (SZSE:300759) Pre-Tax Income Explanation

Pharmaron Beijing Co's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=268.619/2670.741
=10.06%

During the past 10 years, Pharmaron Beijing Co's highest Pretax Margin was 25.70%. The lowest was 3.66%. And the median was 14.72%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmaron Beijing Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Pharmaron Beijing Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmaron Beijing Co (SZSE:300759) Business Description

Traded in Other Exchanges
Address
No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Hong Kong, HKG
Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. Its operating segment includes Laboratory services; CMC (small molecule CDMO) services; Clinical development services and biologics and CGT services. The company generates maximum revenue from Laboratory services segment.
Executives
Lou Xiao Qiang Directors, executives
Zheng Bei Directors, executives

Pharmaron Beijing Co (SZSE:300759) Headlines

No Headlines